Universal screening for type one diabetes: a necessary shift in pediatrics

Published on May 23, 2026 | Translated from Spanish

A 10-year study in Germany, published in JAMA, suggests that early detection of type 1 diabetes should be extended to all children, not just those with a family history. With more than 220,000 participants, the results show that 81% of detected cases came from universal screening, sparking debate about its implementation in public health systems.

Pediatric clinic scene with a young child holding a small blood droplet collection device, nurse using a tablet showing automated immunoassay analyzer results, graphical interface displaying positive islet autoantibody markers, laboratory robotic arm processing a blood sample vial, diverse children in waiting area representing universal screening, clinical ambient lighting, photorealistic medical illustration, clean white examination room, modern diagnostic equipment, focused action of sample transfer and data analysis, crisp technical details, cinematic depth of field

Algorithms and autoantibodies: the technology behind screening 🧬

The study used autoantibody analysis on dried blood samples, a technique that allows identification of stages 1 and 2 of type 1 diabetes before clinical symptoms appear. Early detection relies on automation systems and population databases that process thousands of samples. Of the 260 children who developed the disease during follow-up, universal screening identified 81%, demonstrating the effectiveness of these methods compared to the family history-based approach.

Spoiler: your grandma isn't always right about sugar 🍬

There's always a relative who insists that diabetes comes from eating too many sweets. Now science shows that, while the birthday cake doesn't help, genetics and autoantibodies are the real culprits. Mass screening could prevent children from arriving at the hospital in crisis, and incidentally, give that aunt who blames everything on candy a break.